Nafarelin Side Effects: Safety Signals and Warnings
Nafarelin safety concerns are compound-specific. The main listed side effects are Hot flashes, Nasal irritation and rhinitis, and Headache. The main warning signals are Nasal congestion or use of nasal decongestant sprays may reduce absorption, Bone density monitoring recommended for treatment >6 months, and Not for use in pregnancy (Category X).
Direct Answer
Nafarelin (Synarel) is FDA-approved for endometriosis and central precocious puberty via intranasal delivery - an unusual route for a peptide drug that demonstrates its unique pharmaceutical development. Phase 3 evidence for both indications is solid. For GnRH agonist research requiring intranasal administration, nafarelin is the validated option.
- Evidence grade
- Level A
- Research status
- FDA Approved
- Category
- Sexual Health
- Best for
- Endometriosis treatment, central precocious puberty, intranasal GnRH agonist research
Reported Side Effects
- Hot flashes
- Nasal irritation and rhinitis
- Headache
- Decreased bone mineral density
- Mood changes
- Vaginal dryness
- Decreased libido
- Acne (initial flare)
Warnings
- Nasal congestion or use of nasal decongestant sprays may reduce absorption
- Bone density monitoring recommended for treatment >6 months
- Not for use in pregnancy (Category X)
- Add-back hormonal therapy recommended for endometriosis treatment beyond 6 months
Known or Plausible Interactions
- Nasal decongestant sprays (may reduce nafarelin absorption - space 2 hours apart)
- Add-back therapy (norethindrone 5 mg/day often used to mitigate bone loss and vasomotor symptoms)
- Topical nasal steroids (may affect absorption)
Regulatory Context
FDA-approved prescription medication (Synarel). Prescription only. Not a controlled substance.
Evidence Snapshot
| Evidence grade | Level A |
|---|---|
| Research status | FDA Approved |
| Best supported outcomes | Endometriosis Pain Relief (Level A), Central Precocious Puberty Treatment (Level A), and Uterine Fibroid Reduction (Level B) |
| Primary citation count | 3 |
| Last reviewed | 2026-06-02 |
Related Guides
How to Cite This Page
ExaminePeptides. "Nafarelin Side Effects: Safety Signals and Warnings." Last reviewed 2026-06-02. https://examinepeptides.com/answers/nafarelin-side-effects-safety/
This static answer page is built for fast indexing and direct citation. It summarizes the matching full evidence review and links back to primary sources where the source database includes them.